PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026Cells2 citationsOpen Access

Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders

View Full Paper
KAKsenia A. AchkasovaPSPavel Vadimovich SubbotinVZVadim Zhukov

Key Points

  • The aim is to examine how cytoskeleton components influence brain development and their link to neurodevelopmental disorders.
  • Summarized knowledge on cytoskeleton components such as microtubules and actin filaments.
  • Analyzed their roles in processes like neuronal progenitor proliferation and synaptogenesis.
  • Discussed pathogenic variants affecting cytoskeletal proteins and their contribution to neurodevelopmental disorders.
  • Detailed roles of cytoskeleton in neuronal migration, polarization, and axon specification.
  • Found that dysfunctions in cytoskeletal components lead to neurodevelopmental disorders like microcephaly and lissencephaly.
  • Linked molecular defects to altered cellular behavior and specific clinical phenotypes in neurodevelopmental disorders.

Abstract

Different components of the cytoskeleton are very important determinants of brain development. They orchestrate multiple cellular processes involved in all phases of cerebral cortex development. In this review, we summarize current knowledge on the components of the cytoskeleton—microtubules, actin filaments, and intermediate filaments—and their roles in cortical development. We provide a detailed analysis of how cytoskeleton molecules control neuronal progenitor proliferation, neuronal migration, polarization, axon and dendrite specification and outgrowth, and synaptogenesis. We further examine how pathogenic variants in genes encoding cytoskeletal proteins or their regulators disrupt particular steps of neurogenesis and contribute to major neurodevelopmental disorders (NDDs). Focusing on NDDs such as microcephaly, lissencephaly, corpus callosum agenesis, and synaptopathies, we discuss consequences of cytoskeletal dysfunctions causing altered cellular behavior and clinical phenotypes. By linking molecular defects to developmental and phenotypic consequences, this review highlights the cytoskeleton as a central element in neurodevelopmental pathologies and underscores its potential as a target for future therapeutic strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Achkasova et al. (2026) studied this question.

synapsesocial.com/papers/69bb9321496e729e62981130https://doi.org/10.3390/cells15060537
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Contribution of rare coding variants to microcephaly in individuals with neurodevelopmental disorders2025 · 4 citations
  2. 2MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search2016 · 722 citations
  3. 3Miller-Dieker Syndrome with der(17)t(12;17)(q24.33;p13.3)pat Presenting with a Potential Risk of Mis-identification as a de novo Submicroscopic Deletion of 17p13.32011 · 10 citations
  4. 4Microtubules Have Opposite Orientation in Axons and Dendrites of Drosophila Neurons2008 · 241 citations
  5. 5An unusual presentation of de novo RAC3 variation in prenatal diagnosis2024 · 7 citations